Stock Events

Stock Events

Invex Therapeutics (IXC.AU) Q1 2024 Earnings

15FebConfirmed

Oct 22

Q4 2022

Q2 2023

Q1 2024

-0.03

0.3

0.64

0.97

Details

Expected EPS

N/A

Actual EPS

-0.029315635583480194

Surprise EPS

-0.03

Surprise Percent

+∞%

Description

Invex Therapeutics (IXC.AU) has reported earnings of -0.029315635583480194 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.